Management of immune thrombocytic purpura and acute coronary syndrome: A double-edged sword!
Treating patients known to have immune thrombocytopenic purpura (ITP) presenting with acute coronary syndrome (ACS) pose challenges, especially if they undergo percutaneous coronary intervention and stenting, as they require certain period of dual anti-platelet medication based up on the type of ste...
Main Authors: | Ashish H. Shah, Richard A. Anderson, Ali Raza Khan, Timothy D. Kinnaird |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-07-01
|
Series: | Hellenic Journal of Cardiology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1109966616301518 |
Similar Items
-
Difficult Management of Coronary Artery Disease in a Patient with Thrombotic Thrombocytopenic Purpura
by: Fatemeh Jorfi, et al.
Published: (2015-10-01) -
Diabetes mellitus de tipo I y púrpura trombocitopénica inmunitaria en una niña
by: José Raúl Zaldívar Ochoa, et al. -
Diabetes mellitus de tipo I y púrpura trombocitopénica inmunitaria en una niña
by: José Raúl Zaldívar Ochoa, et al. -
Thrombocytosis following splenectomy and aortic valve replacement for idiopathic thrombocytopaenic purpura with bicuspid aortic valve
by: Sarika Katiyar, et al.
Published: (2015-01-01) -
PERCUTANEOUS CORONARY INTERVENTIONS – CURRENT STATE OF DEVELOPMENT: STENTS EVOLUTION
by: Chernyak A. A., et al.
Published: (2020-11-01)